Key result
A31P and A74T polymorphisms are not linked to feline HCM, indicating low penetrance.
Why the study?
The genetic association between A31P and A74T polymorphisms in the myosin binding protein C3 gene and hypertrophic cardiomyopathy in cats was uncertain.
Do A31P and A74T polymorphisms in the myosin binding protein C3 gene predict hypertrophic cardiomyopathy in Maine Coon and other breed cats?
Observational (n=151)
Do A31P and A74T polymorphisms in the myosin binding protein C3 gene predict hypertrophic cardiomyopathy in Maine Coon and other breed cats?
p-value: p=0.47
The A31P and A74T genetic tests for hypertrophic cardiomyopathy in cats have low predictive value and low penetrance, as many cats with the mutations remain healthy.
A31P/A74T testing should not yet guide feline HCM screening; leaves open the SNPs' diagnostic value pending larger validation.
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an inherited autosomal dominant trait in cats. The A31P single nucleotide polymorphism (SNP) in the myosin binding protein C 3 gene is thought to be the causative mutation in Maine Coon cats. Additionally, the A74T SNP is offered as a genetic test for HCM. OBJECTIVES: To evaluate the genetic association between the above-mentioned SNPs and phenotypes. ANIMALS: Eighty-three Maine Coon cats and 68 cats of other breeds. METHODS: The study was performed prospectively. Cats were phenotyped as healthy or HCM with echocardiography. Taqman genotyping assays were used for genotyping; results were confirmed by sequencing analysis. RESULTS: A31P was found in 18/83 (22%) Maine Coon cats. Fifteen of 18 Maine Coons (83%) with the A31P mutation were healthy on echocardiographic examination (mean age 65 months). A74T was present in 28/79 (35%) of Maine Coons and in 42/68 (62%) of other cat breeds. Twenty-two of 28 (79%) of Maine Coons and 21/42 (62%) of other breed cats with the A74T mutation were healthy at a mean age of 72 months and 91 months, respectively. Of 12 Maine Coons with HCM, 9 (75%) were genotype-negative for A31P and 6 (50%) for A74T. Allele frequencies did not differ significantly (P= .47) between phenotype groups. None of the evaluated genetic tests was able to provide useful predictive information of disease outcome. CONCLUSIONS AND CLINICAL IMPORTANCE: The value of currently available genetic tests is low in the cats of this study. The mutations analyzed appear to have a low penetrance, and even homozygote cats can remain healthy.
No takes yet. Share an insight, caveat, or question.
Wess et al. (2010) conducted an observational in Hypertrophic cardiomyopathy (HCM) (n=151). A31P and A74T polymorphisms vs. Absence of A31P and A74T polymorphisms was evaluated on Hypertrophic cardiomyopathy phenotype (p=0.47). The A31P and A74T polymorphisms were not significantly associated with hypertrophic cardiomyopathy in Maine Coon and other breed cats (P=0.47), indicating low penetrance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: